290 related articles for article (PubMed ID: 18343239)
21. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.
Baena-Cagnani CE; Patel P
Curr Med Res Opin; 2010 Sep; 26(9):2047-55. PubMed ID: 20629597
[TBL] [Abstract][Full Text] [Related]
22. Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis.
Berkowitz RB; Bernstein DI; LaForce C; Pedinoff AJ; Rooklin AR; Damaraju CR; Mesarina-Wicki B; Nolop KB
Allergy; 1999 Jan; 54(1):64-9. PubMed ID: 10195359
[TBL] [Abstract][Full Text] [Related]
23. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
[TBL] [Abstract][Full Text] [Related]
24. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.
Prenner BM; Lanier BQ; Bernstein DI; Shekar T; Teper A
J Allergy Clin Immunol; 2010 Jun; 125(6):1247-1253.e5. PubMed ID: 20434199
[TBL] [Abstract][Full Text] [Related]
25. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis.
Ratner PH; Meltzer EO; Teper A
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):651-7. PubMed ID: 19233485
[TBL] [Abstract][Full Text] [Related]
26. Mometasone furoate nasal spray: a review of safety and systemic effects.
Zitt M; Kosoglou T; Hubbell J
Drug Saf; 2007; 30(4):317-26. PubMed ID: 17408308
[TBL] [Abstract][Full Text] [Related]
27. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
Stanaland BE
Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
[TBL] [Abstract][Full Text] [Related]
28. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
[TBL] [Abstract][Full Text] [Related]
30. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
31. Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children.
Chur V; Small CB; Stryszak P; Teper A
Pediatr Allergy Immunol; 2013 Feb; 24(1):33-8. PubMed ID: 23331528
[TBL] [Abstract][Full Text] [Related]
32. Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.
Schenkel E
Expert Opin Pharmacother; 2003 Sep; 4(9):1579-91. PubMed ID: 12943488
[TBL] [Abstract][Full Text] [Related]
33. Symptom suppression in subjects with perennial allergic rhinitis treated with mometasone furoate nasal spray.
Clement P; Gates D
Int Arch Allergy Immunol; 2012; 157(4):387-90. PubMed ID: 22123158
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of mometasone furoate and biological activity of the metabolites.
Sahasranaman S; Issar M; Hochhaus G
Drug Metab Dispos; 2006 Feb; 34(2):225-33. PubMed ID: 16251254
[TBL] [Abstract][Full Text] [Related]
35. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis.
Naclerio R
Otolaryngol Head Neck Surg; 2008 Feb; 138(2):129-39. PubMed ID: 18241703
[TBL] [Abstract][Full Text] [Related]
36. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.
Brannan MD; Herron JM; Affrime MB
Clin Ther; 1997; 19(6):1330-9. PubMed ID: 9444443
[TBL] [Abstract][Full Text] [Related]
38. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost.
Herman H
Am J Rhinol; 2007; 21(1):70-9. PubMed ID: 17283565
[TBL] [Abstract][Full Text] [Related]
39. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone.
Naclerio RM; Baroody FM; Bidani N; De Tineo M; Penney BC
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):220-7. PubMed ID: 12601318
[TBL] [Abstract][Full Text] [Related]
40. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray.
Graft D; Aaronson D; Chervinsky P; Kaiser H; Melamed J; Pedinoff A; Rosen JP; Schenkel EJ; Vandewalker ML; Keim A; Jensen PK; Nolop K; Mesarina-Wicki B
J Allergy Clin Immunol; 1996 Oct; 98(4):724-31. PubMed ID: 8876546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
